All News

Look at this list of Biosimilars to TNFis! How would you decide what to use? The cost to the payer & what might be imposed? #EULAR2019 https://t.co/DhshdumsXO
Dr Irwin Lim _connectedcare ( View Tweet)
In GCA, concomitant PMR might separate out better prognosis phenotype. Mortality benefit in PMR-relevant OR 0.68 (0.58-0.80). Phenotypes important moving forward in therapeutic selection? #EULAR2019 THU0295 from U La Paz, Madrid @RheumNow https://t.co/4viMygbTcP
David Liew drdavidliew ( View Tweet)
Good morning #EULAR2019 delegates. Come by and visit, meet the Editor! https://t.co/DagNuxGfDq
The Journal of Rheumatology jrheum ( View Tweet)
Cool data presented at #EULAR2019 by @CreakyJoints #ArthritisPower https://t.co/ZtFUsEiboR

Links:

Seth D. Ginsberg SethSaidSo ( View Tweet)

Think: Do you really need to repeat another ANA test?🤔 👉🏼Repeat Antinuclear #antibody testing after a negative result had limited utility in diagnosis of ANA associated rheumatological conditions Via Ai Li Yeo #EULAR2019 OP0020 @RheumNow #immunology #rheumedu https://t.co/eK7GTRn8Z7
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
OP0315. In ERA CATCH cohort fatigue final improvement lags behin remission by approx 6 months. So tell pts with RA that maximal improvement in fatigue lags a bit. #EULAR2019 @RheumNow

Janet Pope Janetbirdope ( View Tweet)

New #EULAR2019 data finds a link between vitamin D deficiency and disease activity among #spondyloarthritis patients. This could help explain the cause of "osteoporosis related to spondyloarthritis, and may adversely affect the patient’s functional status and quality of life."

CreakyJoints.org CreakyJoints ( View Tweet)

There is no clear relationship between ANCA titer and vasculitis relapse, but patients with negative ANCA seem to have less relapses. #EULAR2019 #vasculitis

Jesús Loarce JesusLoarce ( View Tweet)

Congratulations to @Yuz6Yusof, awarded best #EULAR2019 abstract! His work 👉🏼recommended monitoring immunoglobulins baseline & b4 rituximab cycles to identify patients at risk of severe infections https://t.co/bOdwVLlXnL
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
Interesting discussion about nocebo effect when swapping to biosimilars. “Cheaper” may trigger this. Health professionals need to understand we are salespeople in many situations. Language, trust, style matter. #EULAR2019 https://t.co/29GP6cmXhQ
Dr Irwin Lim _connectedcare ( View Tweet)
Optimal bimekizumab dose in PsA still remains to be determined.

Stefan Siebert StefanSiebert1 ( View Tweet)

Ritchlin: Bimekizumab (anti-IL17A & F) Phase 2B in active PsA = rapid response but also further increases wk12 to wk20 and sustained to wk48. #eular2019 @RheumNow https://t.co/yblCNmTxR4
Stefan Siebert StefanSiebert1 ( View Tweet)
@_connectedcare @RheumNow Certainly good rationale for also blocking IL-17F from pathophysiology point of view but will need to see if leads to diffs in RCTs…may also be important for IBD/other conditions

Stefan Siebert StefanSiebert1 ( View Tweet)

@StefanSiebert1 @RheumNow Do you think (gut feel) the combined inhibition of A & F looks better than IL17A inhibition alone? I know hard to compare without H2H but given you’re in this field of research...#eular2019

Dr Irwin Lim _connectedcare ( View Tweet)

RELIEF clinical trial to evaluate efficacy a treatment for #Behçet's Syndrome.. #Apremilast 30 BID demonstrated efficacy at week 12 decreases activity in number and pain of oral ulcers.. - Gulen Hatemi #EULAR2019 https://t.co/iQHErUBIeO
Dr.Martínez MtzReuma ( View Tweet)
GIACTA follow-up #eular2019 RT @drdavidliew: Flares: well, I had hoped for more from that top highlighted line. What is going to happen to our real-life patients who have had a year of TCZ and then come off? https://t.co/iGQN5HjADd
Dr Irwin Lim _connectedcare ( View Tweet)
Motivating presentation on how to bring the future to the present, by Prof. McInnes. Identifying clusters of patients with PsA using Machine Learning. First step to achieve a personalized treatment for every patient #EULAR2019 https://t.co/5xRECw0gG5
Diego Benavent Núñez DiegoBenavent ( View Tweet)
In a large Danish study of #RA patients, those on #biologics and those on conventional #DMARDs had the same incidence of #jointreplacement #EULAR2019 https://t.co/ZgdkVZ8sYa
CreakyJoints.org CreakyJoints ( View Tweet)
Ross Wilkie and his team found walking frequency, depression and insomnia are #mediators of #osteoarthritis effects on #mortality. https://t.co/sXhff6moFd

Links:

OACOP KeeleOACOP ( View Tweet)

What happens to the #muscles in patients with Giant Cell Arteritis after prolonged #steroid treatment?🤔 Find out at #EULAR2019 poster THU0605 Dr Alfuraih will explain using #ultrasound #shearwave #elastography #muscle #imaging https://t.co/VrzfdNiE3I
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
×